Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program February 3, 2026
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care February 2, 2026
Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency October 21, 2025
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development October 7, 2025
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial July 31, 2025
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development July 16, 2025
